Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $26.25, but opened at $23.56. Pediatrix Medical Group shares last traded at $26.4880, with a volume of 346,917 shares trading hands.
Analysts Set New Price Targets
MD has been the topic of several analyst reports. Jefferies Financial Group reissued a “buy” rating and set a $27.00 price target on shares of Pediatrix Medical Group in a research report on Monday, April 20th. UBS Group lifted their target price on Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Mizuho set a $24.00 target price on Pediatrix Medical Group in a report on Friday, May 8th. Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Wednesday, June 24th. Finally, Truist Financial raised their price target on Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. One analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $23.33.
Read Our Latest Analysis on Pediatrix Medical Group
Pediatrix Medical Group Trading Down 4.7%
Pediatrix Medical Group (NYSE:MD – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.04. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. During the same period in the previous year, the business posted $0.53 EPS. The business’s revenue was up 4.1% compared to the same quarter last year. On average, research analysts expect that Pediatrix Medical Group, Inc. will post 2.1 EPS for the current fiscal year.
Insider Transactions at Pediatrix Medical Group
In other Pediatrix Medical Group news, Director Shirley A. Weis sold 36,028 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total value of $855,665.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 1.80% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Pediatrix Medical Group
Several institutional investors and hedge funds have recently modified their holdings of MD. Keybank National Association OH raised its stake in Pediatrix Medical Group by 2.0% in the 1st quarter. Keybank National Association OH now owns 22,941 shares of the company’s stock valued at $491,000 after acquiring an additional 458 shares during the period. Gotham Asset Management LLC raised its stake in shares of Pediatrix Medical Group by 0.6% during the 3rd quarter. Gotham Asset Management LLC now owns 116,093 shares of the company’s stock valued at $1,945,000 after purchasing an additional 724 shares during the period. ProShare Advisors LLC lifted its holdings in Pediatrix Medical Group by 4.6% during the 4th quarter. ProShare Advisors LLC now owns 16,816 shares of the company’s stock worth $360,000 after purchasing an additional 734 shares in the last quarter. Verition Fund Management LLC boosted its stake in Pediatrix Medical Group by 4.4% in the 3rd quarter. Verition Fund Management LLC now owns 25,408 shares of the company’s stock worth $426,000 after purchasing an additional 1,066 shares during the period. Finally, EverSource Wealth Advisors LLC increased its position in shares of Pediatrix Medical Group by 77.7% during the first quarter. EverSource Wealth Advisors LLC now owns 2,515 shares of the company’s stock valued at $54,000 after buying an additional 1,100 shares during the period. 97.71% of the stock is currently owned by institutional investors and hedge funds.
About Pediatrix Medical Group
Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.
Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.
Read More
- Five stocks we like better than Pediatrix Medical Group
- Apple’s AI Strategy Looks Different—Will It Pay Off?
- The AI Chip Stock Making a Quiet Move Toward Dominance
- Why Walmart and Amazon Could Be the Market’s Most Complementary Mega-Caps
- Dodging Deutsche Telekom: T-Mobile’s Strategic Win
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
